Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-22

Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating the safety and efficacy of esomeprazole for non-alcoholic fatty liver disease and nonalcoholic steatohepatitis is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: Sadat City University | Conditions: Fatty Liver Disease, Steatohepatitis, Nonalcoholic | Phase 1, Phase 2 | Status: RECRUITING